Your browser doesn't support javascript.
Inflammatory popliteal aneurysm associated with SARS-CoV-2 infection.
Berchiolli, R; Torri, L; Adami, D; Bertagna, G; Canovaro, F; Troisi, N.
  • Berchiolli R; Vascular Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy. troisimd@gmail.com.
Eur Rev Med Pharmacol Sci ; 27(4): 1708-1712, 2023 02.
Article in English | MEDLINE | ID: covidwho-2251888
ABSTRACT

BACKGROUND:

SARS-CoV-2 infection involves the phase of viral replication and inflammatory response predicting the severity of COVID-19. Vascular involvement in SARS-CoV-2 infection has been well established. Thrombotic complications are common, while only few cases of dilatative diseases have been reported. CASE REPORT We herein report the case of a 65-year-old male patient with an inflammatory 25-mm saccular popliteal artery aneurysm detected six months after symptomatic COVID-19 (pneumonia, and pulmonary embolism). The popliteal aneurysm was surgically managed with aneurysmectomy, and reversed bifurcated vein graft. Histological examination detected the infiltration of monocytes and lymphoid cells into the arterial wall.

CONCLUSIONS:

Popliteal aneurysm could be related to inflammatory response related to SARS-CoV-2 infection. The aneurysmal disease should be considered mycotic and surgically managed without prosthetic grafts.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Popliteal Artery Aneurysm Type of study: Case report / Prognostic study Limits: Aged / Humans / Male Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2023 Document Type: Article Affiliation country: Eurrev_202302_31414

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Popliteal Artery Aneurysm Type of study: Case report / Prognostic study Limits: Aged / Humans / Male Language: English Journal: Eur Rev Med Pharmacol Sci Journal subject: Pharmacology / Toxicology Year: 2023 Document Type: Article Affiliation country: Eurrev_202302_31414